PhenomeX is a Digital Cell Biology company focused on enabling and accelerating the development and commercialization of biotherapeutics and other cell-based products. The Berkeley Lights Platform captures deep phenotypic, functional and genotypic information for single cells in parallel and can also deliver the live biology customers desire in the form of the cells. Co.'s platform captures and interprets the qualitative language of biology and translates it into single-cell specific digital information, referred to as Digital Cell Biology. Co. is focused on the markets of antibody therapeutics, cell therapy and synthetic biology with its platform. We show 3 historical shares outstanding datapoints in our CELL shares outstanding history coverage, used to compute CELL market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CELL market cap history over the course of time is important for investors
interested in comparing CELL's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CELL versus a peer is one thing; comparing
CELL market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CELL can fluctuate over the course of history.
With this page we aim to empower investors researching CELL by allowing them to research the CELL market cap history. |
Free CELL Email Alerts:
Video: The Importance of Market Cap
